We offer disease-relevant models for efficacy testing of drug candidates in all relevant therapeutic areas of respiratory medicine. We are committed to enabling reliable prediction of the efficacy of drug candidates – by constant development of new methods in collaboration with academic institutions and research centers.
Assessing the efficacy of a drug substance requires an understanding of biological and pathological mechanisms and their impact on the patient’s living conditions. Our therapeutically relevant models, therefore, are based not only on a broad variety of cells, tissues, and laboratory animals such as rodents and non-human primates, but also elucidate different disease aspects. We cover all therapeutically relevant diseases of the respiratory tract: from COPD and asthma to infections via pulmonary fibrosis and tumors.